While social determinants of health can impact access to care and treatment options for many patients with cancer, when combined with the complexities of acute myeloid leukemia, these factors become critical to treatment outcomes and quality of life for patients. In this episode, CANCER BUZZ speaks with Linda Hayward, patient financial advocate at the University of Maryland, Kaufman Cancer Center at Upper Chesapeake Health, about the challenges of treatment and strategies to address disparities in access and care for patients with acute myeloid leukemia.
“When patients are financially underserved [this] plays a major factor in a patient getting treatment…if we [financial advocates] were not here to help our patients, many would forgo treatments.” –Linda Hayward, Patient Financial Advocate
“Patient financial advocates can help patients navigate different resources……if we [financial advocates] were not here to help our patients, many would forgo treatments.” –Linda Hayward, Patient Financial Advocate
Guest:
Linda Hayward
Patient Financial Advocate
University of Maryland, Kaufman Cancer Center at Upper Chesapeake Health
Bel Air, Maryland
This episode was developed as a part of the ACCC education program Addressing Disparities in Access to Care for Acute Myeloid Leukemia, designed to explores the current challenges in care coordination and therapy options for patients with acute myeloid leukemia and highlights strategies and best practices to improve outcomes for these patients. This episode was made possible with support by AbbVie.
Additional Reading/Sources
· Strategies to Addressing Disparities in Patients with AML [Video Podcast]
· Improving Care Delivery for Transplant-Ineligible Patients with AML
· ACCC Financial Advocacy Service Guidelines
· AML Care Coordination in the Community Setting [Video Podcast]
· Critical Conversation Strategies for Patients with AML [Video Podcast]
· Shared Decision-making in Acute Myeloid Leukemia
· Achieving and Maintaining Better Outcomes for Patients with AML
· Talking about Acute Myeloid Leukemia (Cancer Support Community)
· Shared Decision-making: Practical Implementation for the Oncology Team (ACCC)
Biomarker Testing for NTRK Gene Fusions
Cancer Care Team Mental Health: Normalizing Helpers Seeking Help
Key Highlights from an ACCC Survey on Remote Patient Monitoring
Alleviating the Psycho-social Burden of MPNs
Myelofibrosis: Advances in Treatment and Therapy
ACCC’s 2023 Advocacy Agenda and Priorities
Symptoms Scoring and Risk Stratification for Myelofibrosis
Utilizing Subcutaneous and IV Treatment for Improved Outcomes with Multiple Myeloma Patients
A Better Patient Experience in the Management of Incidental Lung Nodules
In the Know: New Treatment Guidelines for Myeloproliferative Neoplasms
Mitigating the Financial Burden of Cancer Diagnostics
Getting the Green Light for Precision Medicine Stewards
The Impact of Integrated Care on Myeloproliferative Neoplasms (MPNs)
Treatment Options for Patients with Multiple Myeloma Who Are Ineligible for Transplant
Best Practices in Caring for Patients with CLL in a Post-COVID Era
Addressing Regional Challenges to Equitable Care for Patients with CLL
Robots, Biologics, and Advocates: Lessons from the Pharmacy
Precision Medicine: Stories from the CRISPR Revolution
The Urgency of MPN Treatment – Why Timing Matters
The Role of Population Health Navigators
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain